In Utero Exposure to Banned PCB Chemicals Tied to Autism Risk

This article originally appeared here.
Share this content:
In Utero Exposure to Banned PCB Chemicals Tied to Autism Risk
In Utero Exposure to Banned PCB Chemicals Tied to Autism Risk

TUESDAY, Aug. 23, 2016 (HealthDay News) -- Children exposed to high levels of polychlorinated biphenyls (PCBs) in utero may have an increased risk of developing autism, according to research published online Aug. 23 in Environmental Health Perspectives.

The study included 1,144 children born in Southern California between 2000 and 2003. Overall, 545 children had been diagnosed with an autism spectrum disorder; another 181 had an intellectual disability, but not autism; 418 had neither diagnosis. The children's mothers had all been enrolled in a prenatal screening program, enabling the researchers to analyze blood samples taken during each woman's second trimester.

The team found that autism spectrum disorder risk was increased for a number of PCB congeners. Particularly strong association was seen for the highest versus lowest quartile of PCB138/158 (adjusted odds ratio, 1.79) and PCB153 (adjusted odds ratio, 1.82).

Use of these chemicals was banned in the 1970s because of concerns about their health effects. But since they do not easily break down, PCBs still linger in the environment -- and in people. "Autism is a complex condition with many different causes, and those causes vary among individuals," lead author Kristen Lyall, Sc.D., an assistant professor at Drexel University's A.J. Drexel Autism Institute in Philadelphia, told HealthDay. The new findings suggest that PCBs could be another one of the "puzzle pieces."

Abstract
Full Text

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

USPSTF Urges Abuse Screening for Reproductive-Aged Women

USPSTF Urges Abuse Screening for Reproductive-Aged Women

Evidence lacking for assessing balance of benefits, harms of screening for abuse of seniors, vulnerable

Five-Day Nitrofurantoin Beats Single-Dose Fosfomycin for UTI

Five-Day Nitrofurantoin Beats Single-Dose Fosfomycin for UTI

Increased likelihood of clinical and microbiological resolution for uncomplicated UTI in women

Exercise Intervention Doesn't Improve Walking Ability in PAD

Exercise Intervention Doesn't Improve Walking Ability in PAD

Smaller mean change from baseline to follow-up in 6-minute walking distance with exercise intervention

is free, fast, and customized just for you!

Already a member?

Sign In Now »